IFN-γ was found to be localized to regions of high PD-L1 expression and T cell infiltrates in tumor, and these tumor-associated CD8+ T cell can further inhibit the antitumor immune response through an IFN-γ-driven increase in PD-L1 expression [68]. The gene discussed is CD8A; the disease is neoplasm.